Lithium response in bipolar disorder correlates with improved cell viability of patient derived cell lines

被引：16

作者：

Paul, Pradip ^{[1
]}

Iyer, Shruti ^{[2
]}

Nadella, Ravi Kumar ^{[1
]}

Nayak, Rashmitha ^{[1
]}

Chellappa, Anirudh S. ^{[1
]}

Ambardar, Sheetal ^{[2
,3
]}

Sud, Reeteka ^{[1
]}

Sukumaran, Salil K. ^{[1
]}

Purushottam, Meera ^{[1
]}

Jain, Sanjeev ^{[1
,3
]}

Viswanath, Biju ^{[1
]}

Rao, Naren P. ^{[1
]}

Narayanaswamy, Janardhanan C. ^{[1
]}

Sivakumar, Palanimuthu T. ^{[1
]}

Kandasamy, Arun ^{[1
]}

Kesavan, Muralidharan ^{[1
]}

Mehta, Urvakhsh Meherwan ^{[1
]}

Venkatasubramanian, Ganesan ^{[1
]}

John, John P. ^{[1
]}

Mukherjee, Odity ^{[2
]}

Kannan, Ramakrishnan ^{[1
]}

Mehta, Bhupesh ^{[1
]}

Kandavel, Thennarasu ^{[1
]}

Binukumar, B. ^{[1
]}

Saini, Jitender ^{[1
]}

Jayarajan, Deepak ^{[1
]}

Shyamsundar, A. ^{[1
]}

Moirangthem, Sydney ^{[1
]}

Kumar, K. G. Vijay ^{[1
]}

Thirthalli, Jagadisha ^{[1
]}

Chandra, Prabha S. ^{[1
]}

Gangadhar, Bangalore N. ^{[1
]}

Murthyl, Pratima ^{[1
]}

Panicker, Mitradas M. ^{[3
]}

Bhalla, Upinder S. ^{[3
]}

Chattarji, Sumantra ^{[2
]}

Benegal, Vivek ^{[1
]}

Varghese, Mathew ^{[1
]}

Reddy, JanardhanY C. ^{[1
]}

Raghu, Padinjat ^{[3
]}

Rao, Mahendra ^{[2
]}

机构：

[1] Natl Inst Mental Hlth & Neurosci NIMHANS, Bengaluru, India

[2] Inst Stem Cell Sci & Regenerat Med InStem, Bengaluru, India

[3] Natl Ctr Biol Sci NCBS, Bengaluru, India

来源：

SCIENTIFIC REPORTS | 2020年 / 10卷 / 01期

基金：

英国医学研究理事会;

关键词：

EXPRESSION; NEURONS; GENE; NEUROPROTECTION; LYMPHOBLASTS; MECHANISMS; PATHWAY; DEATH;

D O I：

10.1038/s41598-020-64202-1

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Lithium is an effective, well-established treatment for bipolar disorder (BD). However, the mechanisms of its action, and reasons for variations in clinical response, are unclear. We used neural precursor cells (NPCs) and lymphoblastoid cell lines (LCLs), from BD patients characterized for clinical response to lithium (using the "Alda scale" and "NIMH Retrospective Life chart method"), to interrogate cellular phenotypes related to both disease and clinical lithium response. NPCs from two biologically related BD patients who differed in their clinical response to lithium were compared with healthy controls. RNA-Seq and analysis, mitochondrial membrane potential (MMP), cell viability, and cell proliferation parameters were assessed, with and without in vitro lithium. These parameters were also examined in LCLs from 25 BD patients (16 lithium responders and 9 non-responders), and 12 controls. MMP was lower in both NPCs and LCLs from BD; but it was reversed with in vitro lithium only in LCLs, and this was unrelated to clinical lithium response. The higher cell proliferation observed in BD was unaffected by in vitro lithium. Cell death was greater in BD. However, LCLs from clinical lithium responders could be rescued by addition of in vitro lithium. In vitro lithium also enhanced BCL2 and GSK3B expression in these cells. Our findings indicate cellular phenotypes related to the disease (MMP, cell proliferation) in both NPCs and LCLs; and those related to clinical lithium response (cell viability, BCL2/GSK3B expression) in LCLs.

引用

页数：10

共 50 条

[31] Lithium Pharmacokinetics in the Perinatal Patient With Bipolar Disorder
Clark, Crystal T.
Newmark, Rebecca L.
Wisner, Katherine L.
Stika, Catherine
Avram, Michael J.
JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (11): : 1385 - 1392
[32] Treatment with lithium of a pregnant patient with a bipolar disorder
Retamal, P
Cantillano, V
REVISTA MEDICA DE CHILE, 2001, 129 (05) : 556 - 560
[33] Characterization of novel patient derived melanoma xenografts and cell lines in response to targeted therapies
Harris, Antoneicka L.
Marlow, Laura
Mathias, Adam
Dawson, Louis
Durham, William
Meshaw, Kenneth
Mullin, Robert
Small, Daniel
Synnott, Aidan
Wu, Kevin
Milosevic, Dragana
Netzel, Brian
Grebe, Stefan
Markovic, Svetomir
Copland, John
CANCER RESEARCH, 2015, 75
[34] Bipolar disorder and gene expression in lymphoblastoid cell lines: The transcriptome screen
McInnis, M
Chen, H
DePaulo, JR
Ross, CA
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2004, 130B (01): : 44 - 44
[35] Stem cell and pluripotency markers of lithium treatment in bipolar mood disorder
Rybakowski, J.
EUROPEAN PSYCHIATRY, 2019, 56 : S645 - S645
[36] Genetic predictors of response to lithium in bipolar disorder
Kelsoe, J
McKinney, R
Shekhtman, T
Gaucher, M
Smith, G
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2004, 130B (01): : 162 - 163
[37] Molecular Mechanisms of Lithium Response in Bipolar Disorder
Schalling, Martin
BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 284S - 284S
[38] Telomere length in bipolar disorder and lithium response
Squassina, Alessio
Pisanu, Claudia
Corbett, Nathan
Alda, Martin
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 (06) : 560 - 567
[39] The In Vitro Effects of Lithium on Telomere Length and Epigenetic Age in Lymphoblastoid Cell Lines From Patients With Bipolar Disorder and Controls
Fries, Gabriel R.
Zamzow, Madeline J.
Colpo, Gabriela D.
Monroy-Jamarillo, Nancy
de Quevedo, Joao
Bowden, Charles L.
Walss-Bass, Consuelo
NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 437 - 437
[40] Biological predictors of lithium response in bipolar disorder
Ikeda, A
Kato, T
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2003, 57 (03) : 243 - 250

← 1 2 3 4 5 →